Protein arginine N-methyltransferases (PRMTs) methylate arginine residues within proteins using S-adenosyl-L-methionine (AdoMet) to form S-adenosyl-L-homocysteine and methylarginine residues. All PRMTs produce ω-N G -monomethylarginine (MMA) residues and either asymmetric ω-
INTRODUCTION
Protein arginine N-methyltransferases (PRMTs) are a family of bi-substrate enzymes that transfer methyl groups from the substrate S-adenosyl-L-methionine (AdoMet) to the arginine residues within substrate proteins, forming the products S-adenosyl-L-homocysteine (AdoHcy) and methylarginine residues. All PRMTs produce ω-N G -monomethylarginine (MMA) residues. However, PRMTs are classified based on the dimethylated product they produce. Type I PRMTs produce asymmetric ω-N G ,N G -dimethylarginine (aDMA), and Type II PRMTs produce symmetric ω-N G ,N G -dimethylarginine (sDMA) residues ( Figure 1 ) [1] .
PRMTs methylate many DNA-and RNA-associated proteins [1] . For example, heterogeneous nuclear ribonucleoproteins (hnRNPs) involved in post-transcriptional processing are substrates for PRMTs. In addition, many proteins associated with chromatin are also substrates for PRMTs, including high mobility group associated proteins, p300 and histones. PRMTs can interact with, and be modified by, other proteins, affecting their substrate specificity and activity [1] . Furthermore, prior post-translational modifications to PRMT substrates can affect arginine methylation activity [2] .
PRMTs methylate histones, and it is partially through this activity that PRMTs are thought to act as transcriptional corepressors or co-activators, as methylated histones associate with effector proteins and transcription factors [1] . Prior post-translational modifications of histones can change the distribution and extent of further modification, including methylation, and this has been referred to as the histone code [3] . For example, acetylation of histone H3 Lys 18 increases Arg 17 methylation by co-activator-associated arginine methyltransferase (CARM1/ PRMT4) [4] . PRMT1 specifically methylates histone H4 Arg 3 and that potentiates p300-mediated histone H4 acetylation [2, 5] . Accordingly, siRNA (small interfering RNA) knock-down of PRMT1 eliminates histone H4 Arg 3 dimethylation and reduces Lys 5 and Lys 12 acetylation. Surprisingly, reduction of PRMT1 activity also reduces acetylation of histone H3 [6] . At the level of the nucleosome, co-ordination of these modifications appears to be synergistic and have a coherent direction. For example, promoter-bound p53 recruits p300, PRMT1 and CARM1, and these enzymes act in a defined and co-operative fashion that ultimately leads to recruitment of additional transcriptional factors to facilitate transcription [7] . The effects of PRMT-mediated histone methylation on transcription are complex, dependent on the extent of other potential post-translational modifications and not completely understood, despite intense study.
PRMT2 was discovered because of its 50 % sequence similarity to the conserved catalytic core of PRMT1. The major difference between PRMTs 1 and 2 is that the latter has an N-terminal SH3 (Src homology 3) domain [8] . Whereas PRMT1 is known to exhibit Type I activity, PRMT2 has not been classified as Type I or II because no unambiguous evidence for methylation activity has been discovered to date for this enzyme [9] [10] [11] [12] [13] [14] . The biological role of PRMT2 has been inferred through its various interactions with different nuclear proteins. It is now generally thought that PRMT enzymes that produce aDMA are called Type I, whereas those that produce sDMA are Type II PRMT2 acts as a transcriptional co-activator primarily through its interaction with nuclear hormone receptors. PRMT2 has been shown to bind to oestrogen receptor α (ERα) [12] , the androgen receptor [11] , the retinoblastoma gene product (RB) [14] and hnRNP (heterogeneous nuclear ribonucleoprotein) E1B-AP5 [10] . Moreover, through its interaction with the ERα, peroxisomeproliferator-activated receptor, progesterone receptor, and the retinoic acid receptor, PRMT2 has been shown to produce a ligand-dependent increase in transcriptional activity [12] . Some studies have shown that the PRMT2 SH3 domain is not important for these interactions [12] , while others suggest that it is required [10] . Mutants of PRMT2 that reduce enzyme affinity for AdoMet appear to eliminate its protein-protein interactions [9, 12] . This circumstantial evidence has led to the suggestion that PRMT2 may have methylation activity.
Here we report, for the first time, direct evidence for PRMT2 methylation activity. We find that PRMT2 methylates histone H4 and compare its activity against this substrate with the previously established activity of PRMT1. We find that, like PRMT1, PRMT2 can methylate a fusion protein of glutathione transferase (GST) and the glycine-and arginine-rich (GAR) region (N-terminal 148 residues) of human fibrillarin (referred to as GST-GAR) as well as the H4-tail (N-terminal tail of histone H4). To measure this activity, we developed an ultra-performance liquid chromatography-tandem MS (UPLC-MS/MS) method for the detection of methylated arginine amino acids derived from acid hydrolysis of methylated products. Using TLC and UPLC-MS/MS we show that PRMT2 is a Type I enzyme and that the ratio of aDMA to MMA produced by both PRMTs 1 and 2 is dependent on the substrate, regardless of rate or K m , suggesting that the reactions for both enzymes are distributive rather than processive. We perform a kinetic characterization of PRMTs 1 and 2 by UPLC-MS/MS and determine that, for PRMT2, the K A s and K m of AdoMet and the K m of histone H4 are similar to those measured for PRMT1. However, we find that the k cat of PRMT2 is approx. 800-fold less than that of PRMT1. Although PRMT2 activity is substantially lower than PRMT1 in vitro, the fact that both enzymes selectively methylate histone H4 suggest that PRMT2, like PRMT1, may act as a transcription co-activator through its methylation activity.
EXPERIMENTAL

Constructs and protein purification
Constructs for GST-PRMT4 (mouse), GST-GAR and GST-PRMT1 (rat) in the pGEX2T plasmids were generously provided by Dr Steven Clarke (Department of Chemistry and Biochemistry, UCLA College of Letters and Science, Molecular Biology Institute, Los Angeles, CA, U.S.A.). The cloning of GST-PRMT2 (human) and His 6 -PRMT6 (human) was as described in [15, 16] . The human PRMT2 catalytic core without the SH3 domain (PRMT2 SH3) was PCR-amplified from pGEX-PRMT2 with the primers 5 -CCG GGA TCC CAT GTG GGG AAG CAC GTG  GAT GAG-3 and 5 -C CAA ATA AAG CAT GAA TTC TCA TCT  CCA G-3 . The product was digested with BamHI and EcoRI and  cloned into pGEX-2T (GE Healthcare) .
As arginine methytransferase activity is not naturally present in prokaryotes [17] , any arginine methyltransferase activity in bacterial cells can be attributed solely to the PRMT being expressed. The expression and purification of His 6 -PRMT6 is described in [16] . All GST-fusion proteins were expressed in Escherichia coli DH5α, grown at 37
• C, and induced with 1.0 mM IPTG (isopropyl β-D-thiogalactoside) for 5 h. Harvested cells were lysed according to previously described methods [18] , except that lysozyme (0.3 mg/ml) and DNase I (25 units/ml) were added. GST-fusion proteins were preliminarily purified using tandem 1 ml GSTrap FF affinity columns (GE Healthcare) according to the manufacturer's directions. For the MS and TLC assays (described below), PRMTs 1 and 2 were further purified using a HiLoad 26/60 Superdex 200 pg column (GE Healthcare) with a buffer containing 50 mM Tris/HCl, pH 7.5, 100 mM NaCl at a flow rate of 3 ml/min. Similar to PRMT1, the volume of elution of PRMT2 by gel filtration is consistent with PRMT2 existing mostly in the dimer form (approx. 150 kDa) (see Supplementary Fig ure S1A at http://www.BiochemJ.org/bj/421/bj4210253add.htm). For the UPLC-MS/MS and TLC assays PRMTs 1 and 2 were quantified using densitometry of Coomassie Brilliant Bluestained SDS/10 %-(w/v)-PAGE gels with a reference standard His 6 -PRMT6, which was quantified via hydrolysis and amino acid analysis as described below. Gel-filtration-purified PRMTs 1 and 2 migrate as two bands on SDS/PAGE gels, corresponding to the GST-tagged and non-tagged forms ( Figure S1B ), as revealed by gel migration and by digestion and removal of the GST-tag by thrombin (results not shown). The concentrations of PRMTs used in the gel assays (see Figure 2 below) were measured using the Bio-Rad protein assay.
Histone H4 was purchased from New England Biolabs, and the labelled concentration of 89 μM was confirmed by UV spectrometry (ε 280 = 5120 M −1 · cm −1 ). The standard amino acids MMA, aDMA, and sDMA were purchased from Sigma. AdoMet (Sigma) was purified to remove contaminating AdoHcy using preparative reverse-phase HPLC (Waters SunFire C 18 19 mm × 150 mm column) with mobile phases of (i) 0.1 % aqueous TFA (trifluoroacetic acid) and (ii) 0.1 % TFA in 35 % (v/v) methanol and a gradient of 1 to 100 % phase (ii) over 30 min at a flow rate of 6 ml/min. The concentration of GST-GAR was estimated by hydrolysis in vacuo with 6 M HCl at 110
• C for 24 h, followed by amino acid analysis performed at the Hospital for Sick Children, Toronto, Canada.
Enzyme assays
Unless stated otherwise, enzyme assays were performed with 0.038 μg/10 μl (58 nM) GST-PRMT1 for 60 min, or 0.144 μg/10 μl (190 nM) GST-PRMT2 for 510 min in methylation buffer [50 mM Hepes, pH 8.0, 10 mM NaCl and 1 mM DTT (dithiothreitol)] at 37
• C (see optimization in Supplementary Fig ure S2 at http://www.BiochemJ.org/bj/421/bj4210253add.htm). The concentrations of enzyme used are consistent with previous PRMT enzymatic studies [16, 19, 20] . The reaction volumes were 60 or 100 μl for PRMTs 1 and 2 respectively. All reactions were stopped by flash-freezing, and the thawed reaction mixtures quantitatively transferred to Waters 300 μl auto-sample inserts on ice. The samples were re-frozen, lyophilized, and the dried samples were hydrolysed in vacuo with 6 M HCl at 110
• C for 24 h. Before analysis, the dried hydrolysed samples were reconstituted in the initial mobile phase conditions for the respective chromatographies (TLC or UPLC) described below. The activities of PRMTs 1 and 2 were measured using a UPLC-MS/MS assay. A Waters Acquity UPLC BEH C 18 column (2.1 mm × 100 mm) was used at a flow rate of 0.15 ml/min at 40
• C. The mobile phases (i) 0.1 % aqueous formic acid and 0.05 % TFA and (ii) 0.1 % formic acid, 0.05 % TFA, and 30 % methanol were used in a linear gradient of 0 to 20 % phase (ii) over 2. Figure S3 at http://www.BiochemJ.org/bj/421/ bj4210253add.htm). Fewer daughter ions were used for the detection of MMA because all but the two identified ions were associated with a large decrease in the signal-to-noise ratio in experimental samples. For Figure 3 , below, only the daughters 74 and 46 m/z, diagnostic for MMA and aDMA respectively, were recorded. The standard aDMA was used at concentrations of 0.001-1 μM and MMA was used at concentrations of 0.003-0.5 μM. Under the best possible conditions the limits of quantification of MMA and aDMA are 0.7 and 0.47 nM respectively and in all cases our experimental samples have at least 10-fold higher analyte concentration than this limit. However, under normal assay conditions, background noise can be present that prompted us to reject, as quantifiable, data with a signal-to-noise ratio of less than 3. Using the above chromatographic conditions a separation of almost 0.5 min was achieved between the retention times of MMA (1.99 min) and aDMA (2.43 min) standards.
The data for bi-substrate enzyme reactions were fitted via reciprocal plots for each fixed substrate concentration and subsequent replot of apparent V max for each fixed substrate according to established methods [21] . The results using this method showed little variation (15 % or less) from the HanesWoolf linearization method or non-linear least squares using SigmaPlot 8 (SYSTAT) to the Michaelis-Menten equation for a Uni Uni reaction for each fixed and series of varied substrate concentrations. For PRMT2 the kinetic parameters are derived by estimating the initial rate using aDMA only because of the much lower limit of quantification for aDMA compared with MMA and the high signal-to-noise ratio observed with the measurement of MMA at low AdoMet concentrations. The aDMA product is the predominant species in the reaction between PRMT2 and histone H4, accounting for greater than 67 % of total methylation.
Peptide synthesis
The N-terminal tail of histone H4 (H4-tail, SGRGKGGKGLGK-GGAKRHRKVW), histone H3 (H3-tail, ARTKQTARKSTG-GKAPRKQLATKAAW) and the core small nuclear ribonucleoprotein (SmB , PPGMRPPPPGMRRGPPPPGMRPPRP) peptides were synthesized via solid-phase peptide synthesis on an Applied Biosystems 433A peptide synthesizer [22, 23] , cleaved [24] and purified by reverse-phase HPLC. The identities of the peptides were confirmed by electrospray ionization UPLC-MS. The peptides were quantified using UV spectrometry (calculated ε 280 = 5500 M −1 ·cm −1 ). The non-methylated R1 (WGGYSRG-GYGGW) and mono-methylated R1(MMA) (WGGYSR (MMA) -GGYGGW) peptides were synthesized by Sigma Genosys and quantified as described previously [16] .
Gel activity assays
Gel assays were performed in methylation buffer with 112.5 μM
S-adenosyl-L-[Me-
14 C]methionine ([ 14 C]AdoMet; 0.925 kBq/μl). The substrates GST-GAR and calf thymus histones were used at concentrations of 0.45 and 0.6 mg/ml respectively, for PRMTs 1, 4 and 6. For PRMT2 the substrate GST-GAR was used at concentrations of 0.45 and 0.9 mg/ml for Figures 2(A) and 2(B) respectively. Calf thymus histones and histone H4 were used at concentrations of 0.8 and 0.2 mg/ml respectively with 225 μM [ 14 C]AdoMet. Where GST-GAR was the substrate, SDS/10 %-PAGE gels were prepared as described previously [25] . When peptides, calf thymus histones or histone H4 were used as the substrate, Tricine/SDS/16.5 %-PAGE gels were prepared according to established methods [26] . A Mini-PROTEAN 3 electrophoresis apparatus (Bio-Rad) was used and dried gels were exposed to storage phosphor screens (Amersham Biosciences) for 96 h.
Reaction progress curves
UPLC-MS/MS reaction mixture progress curves were prepared in methylation buffer, similar to the above MS assay, for the substrates GST-GAR (0.9 mg/ml), H4-tail peptide (200 μM), histone H4 (9 and 24 μM for PRMTs 1 and 2 respectively) and AdoMet (100 μM). Reactions for the TLC assay were performed in methylation buffer, similar to the gel assays, except the dried reaction mixtures were desalted with 90 % (v/v) acetone, incubated at − 20 • C for 16 h, followed by centrifugation at 5000 g for 10 min and the supernatant aspirated. The pelleted material was dried in a vacuum centrifuge prior to acid hydrolysis as described above. The wash step is critical to remove decomposition products of [ 14 C]AdoMet, which form during hydrolysis and confound TLC analyses [16] . Glass-backed silica TLC plates (5 cm × 20 cm) were spotted with 10 % of the hydrolysed reaction mixture, with the exception of the reaction with histone H4 and PRMT2, in which 225 μM [ 14 C]AdoMet (1.85 kBq/μl) and 0.288 μg/10 μl PRMT2 were used in a volume of 20 μl and 50 % of the hydrolysed reaction was spotted. For the MS progress curves at the longest time points, the total product (both aDMA and MMA) for the reactions with PRMT1 amount to no more than 4 % of the substrate. For the kinetic analysis the initial formation of product amounts to no more than 0.5 % of the added substrate. In all cases, the amount of product produced is well below the added substrate, resulting in little effective change in the substrate concentration throughout the incubation.
RESULTS
PRMT2 activity and substrate specificity
Although some studies have shown a role for PRMT2 in transcription, through its interactions with nuclear hormone receptors, these studies have failed to demonstrate direct evidence for any methylation activity by PRMT2 [9] [10] [11] [12] [13] [14] . Typically, PRMT enzymes have been found to methylate GAR regions within substrates. A canonical methyl-accepting substrate of this type is GST-GAR, which is partially degraded during purification and migrates as a series of bands between 25-37 kDa on SDS/PAGE [27] . Although full-length GST-GAR is 41 kDa, it migrates at approx. 64 kDa, consistent with other highly positively charged PRMT substrates [28] . Despite the fragmented nature of this substrate, GST-GAR is a widely used general methylaccepting substrate for comparing PRMT activity. To detect and compare PRMT2 activity with other PRMTs, we expressed and purified GST-PRMT1, GST-PRMT2, GST-PRMT4 and His 6 -PRMT6. These enzymes were incubated with GST-GAR and [
14 C]AdoMet in an optimized methylation buffer (Supplementary Figure S2) described in the Experimental section. Subsequent separation using SDS/PAGE and detection of incorporated radioactivity via storage phosphor screen revealed a small but detectable above-background signal from PRMT2 ( Figure 2A) .
In order to confirm that observed PRMT2 activity is enzymedependent, PRMT2 was titrated into a series of reaction mixtures with GST-GAR and analysed as described above. The results show a PRMT2-dependent increase in radioactive methyl groups transferred to GST-GAR ( Figure 2B ), confirming that the activity observed is due to PRMT2. Furthermore, the increase in methylation activity is linear with respect to the amount of PRMT2 present from 0.14 to 0.86 μg. At higher concentrations of PRMT2, a high molecular mass band is methylated, which we attribute to full-length GST-GAR rather than PRMT2 automethylation, as controls with PRMT2 alone show no significant automethylation activity ( Supplementary Figure S2A, lane 6) . Apparent enzyme-independent radioactivity associated with GST-GAR ( Figure 2B , lane 1) does indicate a background activity that must be taken into account when assessing methyltransferase activity, underscoring the importance of demonstrating enzyme-dependent activity with this substrate. Importantly, this background signal is not formed by the presence of methylated arginine residues (results not shown). Furthermore, we did not observe significant background of the type observed with GST-GAR using storage phosphor screens for any of the other substrates used in the present study (results not shown).
Previous studies provided no direct evidence for activity from either wild-type PRMT2 or a mutant PRMT2 that does not contain its SH3 domain (PRMT2 SH3) [9] [10] [11] [12] [13] [14] . Although we can detect activity from PRMT2 with GST-GAR, we do not detect any above background activity for PRMT2 SH3 (Supplementary Figure  S4A at http://www.BiochemJ.org/bj/421/bj4210253add.htm). We also found that the activity of PRMT2 was not affected by the presence or absence of the affinity GST-tag ( Figure S4B ).
Having determined that recombinant PRMT2 is an active enzyme, we compared its substrate specificity with that of PRMTs 1, 4, and 6. Consistent with previous results with full-length histones, PRMT1 methylated histone H4 and to some extent histone H3 and H2A/B. PRMT4 primarily methylated histone H3, whereas PRMT6 methylated histones H4, H3 and H2A/B ( Figure 2C ). As with PRMT1 the preferred histone substrate for PRMT2 is histone H4. In order to confirm this substrate preference, PRMT2 was incubated with recombinant histone H4, showing that it is indeed methylated by PRMT2 ( Figure 2C , lane 5). Synthetic peptides of the N-terminal tails of histone H4 and H3 were also tested as substrates for PRMT2. Only the H4 tail peptide appears to produce very low activity that is below the limit of quantification (see Supplementary Figure S5 at http://www.BiochemJ.org/bj/421/bj4210253add.htm). The SmB peptide, which has been shown to bind to the SH3 domain of PRMT2 [29] , is not methylated (results not shown). 
PRMT2 is a Type I enzyme
PRMTs are classified as either Type I or Type II enzymes (Figure 1) . Although the similarity in amino acid sequence between PRMTs 1 and 2 suggests that PRMT2 is a Type I enzyme, its apparent lack of methylation activity has, to this point, prevented a formal classification. Using a TLC method capable of separating aDMA, sDMA and MMA derived from acid hydrolysis of PRMT reactions as described in [16] , we determined the type of methylation activity for PRMT2. The TLC results of a reaction with PRMT2, [ 14 C]AdoMet and GST-GAR show that PRMT2 produces MMA and aDMA ( Figure 3A) , demonstrating that it is a Type I enzyme. To support this finding we developed a UPLC-MS/MS assay for the separation and unambiguous detection of aDMA and MMA derived from the acid hydrolysis of PRMT reactions using characteristic retention times and fragment ions (see Supplementary Figure S3 ). The reaction above was repeated with unlabelled AdoMet and analysed using UPLC-MS/MS. The resulting chromatogram in Figure 3 (B) (upper panel) shows a peak with the characteristic retention time and a previously described fragment ion dimethylammonium, indicative of aDMA [30, 31] . MMA is also detected using the characteristic retention time and fragment ion methylguanidine ( Figure 3B , lower panel) [32] . These results confirm our TLC data that demonstrate PRMT2 exhibits Type I activity.
Enzyme progress curves for PRMTs 1 and 2
PRMT2 was further characterized and compared with PRMT1 using UPLC-MS/MS progress curves and TLC. The rate of production of MMA, aDMA and total methylation for PRMT1 with the substrate GST-GAR is depicted in Figure 4 (A). There is a linear relationship up to 6 h and aDMA is the predominant methylated product. In contrast, PRMT2 has a lower rate of methylation, which is linear up to 9 h, and produces more MMA than aDMA when GST-GAR is the substrate (Figure 4B ).
The rate of methylation of histone H4 was also measured in progress curves for PRMTs 1 and 2. For PRMT1, the rate of methylation is linear up to 2 h, and the production of aDMA is higher than MMA ( Figure 4C ). The rate plateaus at this point because the amount of product approaches 4 % for the total added substrate. For PRMT2, the rate of methylation of histone H4 is much lower than that found for PRMT1, is linear up to at least 9 h, and, unlike GST-GAR, results in a higher production of aDMA over MMA ( Figure 4D ). For the purpose of comparison with the full-length histone H4, the H4-tail peptide is used as the substrate for reactions with PRMTs 1 and 2. Figure 4 (E) shows the rate of methylation of the H4-tail peptide by PRMT1. In contrast with full-length histone H4 (Figure 4C ), the rate of methylation is linear up to 6 h, and more MMA is produced than aDMA. For PRMT2 the signal-to-noise ratio is insufficient for accurate quantification of MMA and aDMA, yet we are able to detect the formation of aDMA and MMA with a H4-tail peptide substrate (see Supplementary Figure S5 at http://www.BiochemJ.org/bj/421/bj4210253add.htm).
PRMTs 1 and 2 were tested for activity against a panel of substrates using TLC ( Figure 4F ) to confirm the results of the UPLC-MS/MS progress curves and to further explore the effect of substrate on the aDMA-to-MMA ratio. The result of the reaction with PRMT1 and GST-GAR is shown in Figure 4 (F), lane 1; aDMA is the predominant product consistent with the results from the UPLC-MS/MS assay ( Figure 4A ). The incubation of PRMT1 with the non-methylated R1 (lane 2) and monomethylated R1(MMA) (lane 3) substrate peptides [16] show that the total radioactivity for the R1(MMA) substrate is similar to that in lane 2 (by densitometry), indicating that a clear preference for the monomethylated substrate is not observed, as with PRMT6 [16] . Interestingly, non-methylated R1 peptide (lane 2) produces 3-fold more aDMA than MMA with PRMT1 [we have taken into account that the addition of two [
14 C]methyl groups (aDMA) on R1 produces twice as much signal as the addition of one (MMA)]. Consistent with the UPLC-MS/MS data with PRMT1, the H4-tail peptide results in higher MMA than aDMA production (lane 4), whereas histone H4 results in the opposite ratio (lane 5). The results of reactions for PRMT2 with GST-GAR (lane 6) and histone H4 (lane 7) are consistent with the UPLC-MS/MS data that show higher production of MMA than aDMA for GST-GAR and the opposite ratio for histone H4.
Kinetic characterization of PRMTs 1 and 2 using histone H4
To determine the kinetic parameters of PRMTs 1 and 2, we performed a steady-state kinetic characterization of both enzymes with histone H4 using the UPLC-MS/MS assay. Both PRMTs 1 and 2 were incubated with increasing concentrations of histone H4 and AdoMet. For both enzymes when either histone H4 or AdoMet concentrations are varied, in the presence of several constant concentrations of the other substrate, the resulting double-reciprocal plots exhibit a pattern of lines that intersect to the left of the y-axis ( Figure 5 ). This pattern is indicative of a sequential bi-substrate enzyme mechanism for PRMTs 1 and 2, and is consistent with our previous studies on PRMT6 [16] . In agreement with all of the comparative data presented thus far, the kinetic study shows that the activity of PRMT1 is much greater than the activity of PRMT2.
The kinetic parameters for PRMTs 1 and 2 with the histone H4 and AdoMet substrates were determined by the double-reciprocal slope and intercept re-plots and are listed in Table 1 . Assuming an ordered sequential bi-substrate reaction the rate of reaction (v) for this mechanism can be described using eqn (1), for which (K 6 and 7) . This panel is brightness-and contrast-adjusted.
The k cat for PRMT1 is almost 800-fold higher than that for PRMT2. The k cat /K m for AdoMet is almost 2000-fold higher for PRMT1 than for PRMT2, and the k cat /K m for histone H4 is nearly 600-fold higher. Surprisingly, the low activity of PRMT2 is not the result of poor substrate affinity, as the K A s and K m for AdoMet and the K m for histone H4 are both relatively low and similar to the values measured for PRMT1.
DISCUSSION
Here we report, for the first time, methylation activity directly attributable to PRMT2 and compare it with PRMT1. The activity is low in comparison with PRMT1 and other PRMTs (Figure 2A ), but it is dependent on the amount of PRMT2 ( Figure 2B ). We demonstrate that PRMT2 catalyses Type I PRMT activity (Figure 3) , and, after testing many substrates, we find that PRMT2 methylates GST-GAR, histone H4 (Figure 4 ), and to a small extent the H4-tail peptide ( Figure S5 ).
Dependence of the aDMA to MMA ratio on substrate
Type I PRMTs are capable of catalysing the formation of aDMA and MMA from arginine residues within substrate proteins. Previous studies have shown that aDMA residues rapidly accumulate to become the major methylated arginine product for Type I enzymes [33] . We have observed, using UPLC-MS/MS progress curves and TLC, that for PRMT1 the amount of aDMA produced is greater than MMA for the substrates GST-GAR, R1, and histone H4, whereas the reverse is true for the H4-tail peptide. PRMT2 produces more MMA than aDMA when GST-GAR is the substrate, but the reverse is true for histone H4.
PRMT1 methylation of the H4-tail, which has been shown to contain a single methylation site [2] , produces more MMA than aDMA, whereas full-length histone H4 results in more aDMA than MMA (Figure 4C and E) . This is true despite PRMT1 having apparently similar K m values for the two substrates Table 1 Kinetic parameters for PRMTs 1 and 2 The values for PRMT1 are listed as mean (S.D.) of two measurements made on separate days. The initial rates for PRMT2 are derived from the amount of aDMA produced rather than total methylation. The errors for PRMT2 are derived from the fit of the parameters. The V max and k cat of PRMT1 are calculated assuming GST-PRMT1 M w = 66 003 g/mol. The V max and k cat of PRMT2 are calculated assuming GST-PRMT2 M w = 74 522 g/mol. *Not available. These values cannot be calculated using the current method of analysis.
Figure 5 Kinetic analysis of PRMTs 1 and 2 as reciprocal plots
The initial velocity of the reaction of histone H4 with PRMT1 was measured (mean + − S.D.) as the total methyl groups transferred (calculated as 2(aDMA) + MMA) derived from acid hydrolysis of the reactions in which (A) the AdoMet concentration was varied at fixed histone H4 concentrations of 2 μM (᭹), 4 μM (), 8 μM (᭺), 16 μM ( ) and 32 μM (ᮀ). These data were re-plotted (B) with varying histone H4 at fixed AdoMet concentrations of 1 μM (᭹), 2.5 μM (), 5 μM (᭺), 10 μM ( ), and 20 μM (ᮀ). The initial velocity of the reaction of histone H4 with PRMT2 was measured as the amount of aDMA in which (C) the AdoMet concentration was varied at fixed histone H4 concentrations of 4 μM (᭹), 8 μM (), 16 μM (᭺), 32 μM ( ) and 52 μM (ᮀ). These data were re-plotted (D) with varying histone H4 at fixed AdoMet concentrations of 5 μM (᭹), 10 μM (), 20 μM (᭺), 40 μM ( ), and 100 μM (ᮀ).
[2.9-32 μM for H4-tail [19, 20] and 4 μM for histone H4 (Table 1) ]. Interestingly, the 12-residue R1 peptide, which also contains only one methylation site, results in the production of more than 3-fold more aDMA than MMA with PRMT1 ( Figure 4F, lane 2) . This outcome suggests that the difference in the ratio of aDMA to MMA observed with PRMT1 and histone H4 or the H4-tail peptide cannot be explained by the shorter length of the H4-tail. We also observed a substrate dependence on the ratio of aDMA to MMA produced with PRMT2. GST-GAR, which is arguably a better substrate for PRMT2 than histone H4 based on its higher rate of methylation ( Figure 4B ), results in more MMA than aDMA, whereas histone H4 shows the opposite ratio of MMA to aDMA ( Figure 4D and F) . Together these results demonstrate that substrate and enzyme determine the relative amounts of aDMA and MMA formed (Figure 4 ).
Distributive enzyme mechanism
For any enzyme capable of catalysing multiple chemical reactions on the same substrate, the mechanism can be processive, where more than one chemical reaction occurs per enzyme-substrate binding event, or distributive, where only one reaction occurs per enzyme-substrate binding event. Therefore, PRMTs that might execute multiple methylations per enzyme-substrate binding event are processive, whereas those PRMTs that catalyse the transfer of a single methyl group per enzyme-substrate binding event are distributive. Several groups have attempted to elucidate the mechanism of multiple methylations for Type I PRMT enzymes [15, 16, 19, 34, 35] . The preponderance of aDMA residues in the products for Type I PRMTs has led many to suggest that these enzymes are processive. In practice, it is difficult to determine if an enzyme is processive. However, given the relatively low level of products to substrate in any enzyme reaction, we can assume that a PRMT is processive if the product formation rate from multiple methyl transfers is as fast, or faster, than the rate of accumulation of products that have undergone a single methyl transfer. Thus, for a substrate with a single methylaccepting arginine residue, one would expect to see accumulation of aDMA that is as fast or faster than the rate of accumulation of MMA if PRMTs are indeed processive. We have shown that for single methyl-accepting substrates of PRMT1 (R1, H4-tail, and histone H4) the substrate determines the ratio of aDMA to MMA produced. Furthermore, we find no clear pattern of evidence to suggest that the K m , rate of reaction, or length of the substrate determine the ratio of aDMA to MMA. These results suggest that it is unlikely that PRMT1 utilizes a processive mechanism. This conclusion is consistent with our previous work on PRMT6 and the results of others for PRMTs 1 and 3 [16, 34, 35] .
We cannot rule out processivity for substrates that contain multiple methyl-accepting arginine residues. MMA could be the predominant methylated product, and processivity could still occur if multiple arginine residues are converted into MMA residues per enzyme-substrate binding event. However, this seems unlikely in the light of structural evidence for PRMT4 [36] and a bacterial O-methyltransferase [37] . Both structures exhibit a disordered N-terminus that, on AdoMet binding, folds into a helix on top of AdoMet, holding the co-substrate in place and forming a groove along which the methyl acceptor can bind. This mechanism implies that the methylated product must dissociate after a single methyl transfer to allow release of AdoHcy and that multiple methyl transfers cannot proceed in a processive manner. In the light of this argument, and the fact that the substrate determines the ratio of aDMA to MMA for PRMT2 regardless of rate and K m , we suspect that it also utilizes a distributive mechanism.
Kinetics of PRMTs 1 and 2
Consistent with our previous study on PRMT6 [16] , we find that kinetic data for PRMTs 1 and 2 reveal a sequential bi-substrate enzyme mechanism, which is probably a common feature for the entire PRMT enzyme family. Kinetic parameters were determined for both enzymes, and, to the best of our knowledge, the current work represents the first complete kinetic characterization of a PRMT enzyme with a full-length protein substrate (i.e. histone H4). The k cat of PRMT1 with histone H4 is comparable with that derived for PRMT6 using the R1 and R1(MMA) substrates, but the k cat /K m for PRMT1 with histone H4 and AdoMet are 25-and 10-fold higher than for PRMT6 with R1(MMA) and AdoMet respectively. This difference is probably caused by the substantially higher K m derived for the R1(MMA) peptide with PRMT6 (K m = 184 μM) [16] . The k cat of PRMT1 is about 800-fold greater than the k cat of PRMT2. However, the low activity of PRMT2 is not the result of poor substrate affinity, since the dissociation constant (K A s ) and K m for AdoMet and the K m for histone H4 are relatively low (i.e. high-affinity binding) and similar to the values measured for PRMT1. While keeping in mind that K m does not reflect a true dissociation constant, this kinetic behaviour suggests that the low activity of PRMT2 may be caused by slow catalysis or product dissociation.
A recent kinetic study on PRMT1 has suggested that PRMT1 utilizes a rapid equilibrium random bi-substrate enzyme mechanism [19] . However, the activity of PRMT1 in that study was assayed with SDS/PAGE followed by phosphorimaging of radiolabelled products, and the diffuse peptide bands produced in these gels can potentially result in a low signal-to-noise ratio. The problem of a low signal-to-noise ratio is compounded when product inhibitor assays are performed. Moreover, the total methylation activity in that study was indirectly quantified using [ 14 C]albumin, which could lead to errors in the estimation of initial enzyme rates. For the data analysis in the present study we assumed a steadystate ordered sequential bi-substrate mechanism for PRMTs 1 and 2, where AdoMet is the first substrate to bind and AdoHcy is the last product to dissociate. This mechanism is supported by structural investigations of PRMT4 and a bacterial O-methyltransferase, which show that AdoMet binding causes the normally disordered N-terminus to form a helix on top of AdoMet, forming a binding ridge for the protein substrate [36, 37] . This structural behaviour suggests ordered substrate binding and release. In addition, our previous kinetic analysis of PRMT6 using a directly quantified and sensitive MS assay demonstrated that PRMT6 displays an ordered sequential bi-substrate mechanism [16] .
The comparatively weak activity of PRMT2
By any objective measure the activity of PRMT2 is very low in comparison with PRMT1, and the accumulation of evidence on the activity of PRMT enzymes seems to suggest that two tiers of recombinant enzymes exist. Some PRMTs, like PRMT1, have very high in vitro activity on a variety of substrates, whereas PRMT2 and PRMT7 [38] have comparatively very low activity. In the case of PRMT7 an incubation of 16 h was required to achieve radioactive signal slightly above background. Regardless, the relatively low activity of PRMT2 appears to be important for its function as a transcriptional co-activator. Previous studies have shown that a mutant of PRMT2 with reduced AdoMetbinding capacity can only enhance ERα transcriptional activity by about 2.5-fold, whereas the enhancement with wild-type PRMT2 is 8-fold [12] . Recently, PRMT2-associated activity from an immunoprecipitate of HEK-293 (human embryonic kidney-293) cell extracts was used to methylate hypomethylated whole-cell extracts [39] . Those authors showed that this PRMT2-associated methylation activity is significantly weaker than PRMT1-associated activity, which is consistent with our in vitro results.
The optimal substrate for PRMT2 may still be unknown. The presence of a polyproline-binding SH3 domain within PRMT2 suggests that proteins with polyproline sequences are potential PRMT2 substrates, notwithstanding the absence of activity with the polyproline-containing SmB peptide. It also may be necessary for PRMT2 to interact with one or more of its many proteinbinding partners to yield high methylation activity. We have already mentioned in the Experimental section that we can rule out contamination of PRMT2 with a bacterial PRMT, since none are known to exist. Finally, it remains a possibility that low activity from any enzyme may be a result of improper or incomplete folding that can occur when a mammalian protein is expressed in bacteria. However, in the case of PRMT2 this seems unlikely to be the cause of its low activity, as previous studies have revealed numerous specific protein-protein interactions with GST-PRMT2 that would require a properly folded protein [9, 10, 12] .
Implications of PRMT2 methylation of histone H4
To this point, the ability of PRMT2 to act as a co-activator of transcription appeared to be mediated primarily though its association with nuclear hormone receptors. The discovery of a small, but significant, methylation activity, from PRMT2 presents the possibility that this enzyme has the ability to modulate transcription through its methylation activity as previously reported for PRMT1 and speculated for PRMT2 [1, 12] . Furthermore, the finding that PRMT2 methylates the H4-tail suggests that its role may be similar to that of PRMT1 ( Figure S5 ). We suspect that PRMT2 methylation of histone H4 may be the mechanism through which PRMT2 acts as a transcriptional co-activator [9, 11, 12, 14] . (A) Gel-filtration purification of affinity-purified GST-PRMT2 using a HiLoad 26/60 Superdex 200 pg column. mAu, milli-absorbance units. (B) Coomassie Blue-stained SDS/10 %-PAGE gel of eluted protein collected as 10 ml fractions. Volumes 100-140 ml correspond to lanes 1-4. Lanes 5 and 6 correspond to elution volumes at 170 and 190 ml. The elution volume of GST-PRMT2 (110-130 ml, lanes 1 and 2) is consistent with a molecular mass of ∼ 150 kDa, suggesting that GST-PRMT2 (74.5 kDa) exists primarily as a dimer, similar to PRMT1. The gel shows that PRMT2 purifies as two bands ∼ 75 and ∼ 51 kDa, which match closely the calculated molecular mass of GST-PRMT2 (74.5 kDa) and PRMT2 (49 kDa). Lane 7 is the concentrated and pooled fractions between 110 and 130 ml, and lane 8 shows concentrated PRMT2 eluted from the GST affinity resin prior to gel filtration purification.
Figure S2 Optimizing the reaction conditions for PRMT2
Reactions with PRMT2 and GST-GAR in 50 mM Hepes at pH 6-9, 1.0 mM DTT and (A) 10-100 mM NaCl or (B) 250-500 mM NaCl were performed. Shown are Coomassie Blue-stained SDS/10 %-PAGE gels (upper panels) and storage phosphor images (lower panels) of the reactions. For each reaction the pH and NaCl concentration are listed above the lane. In (A) lane 5 is a no-enzyme control (note the background signal) and lane 6 is a no-substrate control (note the lack of automethylation). Ideal reaction conditions for PRMT2 appear to be low salt and high pH (i.e. 10 mM NaCl and pH 8).
1 To whom correspondence should be addressed (email afrankel@interchange.ubc.ca). The structure and mass of each parent ion is displayed on the far right, and the structures of diagnostic fragment ions are displayed above, or immediately to the right of, the corresponding peak. 1-7 respectively) . Shown are the Coomassie Blue-stained gel (upper panel; coomassie) and corresponding storage phosphor image (lower panel; storage phosphor). No signal above background was found for PRMT2 SH3. The positions of full length GST-GAR and GST-PRMT2 SH3 are indicated as are the molecular mass markers 37 and 25 kDa, where the fragments of GST-GAR migrate. (B) Image from a storage phosphor screen exposed to a TLC with hydrolysed reaction mixtures containing GST-PRMT2 (lane 1) and PRMT2 without the GST domain (lane 2). The GST tag was removed by digestion with thrombin (Sigma) for 1 h, followed by treatment with a thrombin affinity resin.
